| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| Pathway | REACTOME_RET_SIGNALING | 4.28e-05 | 38 | 73 | 4 | MM15493 | |
| Pathway | REACTOME_RET_SIGNALING | 5.25e-05 | 40 | 73 | 4 | M27746 | |
| Pathway | REACTOME_TIE2_SIGNALING | 8.60e-05 | 17 | 73 | 3 | MM14836 | |
| Pathway | REACTOME_TIE2_SIGNALING | 1.03e-04 | 18 | 73 | 3 | M11932 | |
| Pubmed | A dual-activity topoisomerase complex regulates mRNA translation and turnover. | VWA5B2 SHC1 TRMT1 RNF40 GRIN2D MBD6 FHIP1B PLEKHG5 PLEKHH3 KCNH3 HOXB4 ARHGEF40 PWWP2B AATK NFATC1 ZNF408 NFKB2 EIF4G1 SNX8 SEC16A TP53I13 DISP2 SOWAHB ARHGAP33 | 1.59e-13 | 1105 | 114 | 24 | 35748872 |
| Pubmed | SASH1 TRIOBP RNF40 PLEKHG5 NACAD AFAP1 MRC2 CACNA1G LZTS2 AMOTL2 | 1.01e-05 | 529 | 114 | 10 | 14621295 | |
| Pubmed | 1.07e-05 | 2 | 114 | 2 | 16936271 | ||
| Pubmed | 1.07e-05 | 2 | 114 | 2 | 16465045 | ||
| Pubmed | 1.07e-05 | 2 | 114 | 2 | 23582017 | ||
| Pubmed | 1.07e-05 | 2 | 114 | 2 | 37056170 | ||
| Pubmed | uPARAP/endo180 directs lysosomal delivery and degradation of collagen IV. | 1.07e-05 | 2 | 114 | 2 | 14729061 | |
| Pubmed | Protein tyrosine phosphatase SHP2 is involved in Semaphorin 4D-induced axon repulsion. | 1.07e-05 | 2 | 114 | 2 | 19433062 | |
| Pubmed | 1.07e-05 | 2 | 114 | 2 | 25692141 | ||
| Pubmed | 1.07e-05 | 2 | 114 | 2 | 20464982 | ||
| Pubmed | A quantitative protein interaction network for the ErbB receptors using protein microarrays. | 1.22e-05 | 90 | 114 | 5 | 16273093 | |
| Pubmed | 3.19e-05 | 3 | 114 | 2 | 23691121 | ||
| Pubmed | 3.19e-05 | 3 | 114 | 2 | 17664338 | ||
| Pubmed | 3.19e-05 | 3 | 114 | 2 | 8940081 | ||
| Pubmed | 3.19e-05 | 3 | 114 | 2 | 37786383 | ||
| Pubmed | 3.19e-05 | 3 | 114 | 2 | 10803466 | ||
| Pubmed | A deep proteomics perspective on CRM1-mediated nuclear export and nucleocytoplasmic partitioning. | EVL NCKIPSD SHC1 APBA3 FRAT2 RUSC2 NFKB2 SEC16A CDT1 SSH2 LZTS2 AMOTL2 MAPK7 | 3.71e-05 | 1038 | 114 | 13 | 26673895 |
| Pubmed | A census of human transcription factors: function, expression and evolution. | ATF7 ZBTB17 E4F1 PGR BNC1 BCL6B HOXB4 NEUROG1 NFATC1 NFKB2 RERE FOXC1 | 4.50e-05 | 908 | 114 | 12 | 19274049 |
| Pubmed | Analysis of BCL6-interacting proteins by tandem mass spectrometry. | 5.27e-05 | 62 | 114 | 4 | 16147992 | |
| Pubmed | 6.36e-05 | 4 | 114 | 2 | 16108830 | ||
| Pubmed | 6.36e-05 | 4 | 114 | 2 | 10080542 | ||
| Pubmed | 6.36e-05 | 4 | 114 | 2 | 12135708 | ||
| Pubmed | 6.36e-05 | 4 | 114 | 2 | 15782119 | ||
| Pubmed | 6.36e-05 | 4 | 114 | 2 | 9824671 | ||
| Pubmed | 6.36e-05 | 4 | 114 | 2 | 20472558 | ||
| Pubmed | 6.36e-05 | 4 | 114 | 2 | 8541543 | ||
| Pubmed | 6.36e-05 | 4 | 114 | 2 | 11707390 | ||
| Pubmed | 6.36e-05 | 4 | 114 | 2 | 10650943 | ||
| Pubmed | A Global Analysis of the Receptor Tyrosine Kinase-Protein Phosphatase Interactome. | 7.64e-05 | 420 | 114 | 8 | 28065597 | |
| Pubmed | NCKIPSD SHC1 TUT1 PLEKHH3 PTPN11 CEP120 NFATC1 SLC4A1AP SSH2 LZTS2 | 9.35e-05 | 689 | 114 | 10 | 36543142 | |
| Pubmed | Fcgamma receptor-mediated inhibition of human B cell activation: the role of SHP-2 phosphatase. | 1.06e-04 | 5 | 114 | 2 | 10382761 | |
| Pubmed | 1.06e-04 | 5 | 114 | 2 | 9886492 | ||
| Pubmed | 1.06e-04 | 5 | 114 | 2 | 9393882 | ||
| Pubmed | 1.06e-04 | 5 | 114 | 2 | 16825188 | ||
| Pubmed | 1.06e-04 | 5 | 114 | 2 | 15888547 | ||
| Pubmed | 1.06e-04 | 5 | 114 | 2 | 11714803 | ||
| Pubmed | 1.06e-04 | 5 | 114 | 2 | 9593725 | ||
| Pubmed | 1.06e-04 | 5 | 114 | 2 | 7907978 | ||
| Pubmed | Pathways downstream of Shc and Grb2 are required for cell transformation by the tpr-Met oncoprotein. | 1.06e-04 | 5 | 114 | 2 | 8662733 | |
| Pubmed | 1.06e-04 | 5 | 114 | 2 | 9804835 | ||
| Pubmed | Characterization of the signaling capacities of the novel gp130-like cytokine receptor. | 1.58e-04 | 6 | 114 | 2 | 15194700 | |
| Pubmed | 1.58e-04 | 6 | 114 | 2 | 36334595 | ||
| Pubmed | 1.58e-04 | 6 | 114 | 2 | 10521483 | ||
| Pubmed | 1.58e-04 | 6 | 114 | 2 | 17485464 | ||
| Pubmed | PKB-mediated negative feedback tightly regulates mitogenic signalling via Gab2. | 1.58e-04 | 6 | 114 | 2 | 11782427 | |
| Pubmed | 1.58e-04 | 6 | 114 | 2 | 8890167 | ||
| Pubmed | An inter-species protein-protein interaction network across vast evolutionary distance. | 1.99e-04 | 483 | 114 | 8 | 27107014 | |
| Pubmed | 2.08e-04 | 35 | 114 | 3 | 23382074 | ||
| Pubmed | 2.21e-04 | 7 | 114 | 2 | 10995764 | ||
| Pubmed | 2.21e-04 | 7 | 114 | 2 | 16371368 | ||
| Pubmed | 2.21e-04 | 7 | 114 | 2 | 28213521 | ||
| Pubmed | 2.21e-04 | 7 | 114 | 2 | 34104947 | ||
| Pubmed | 2.21e-04 | 7 | 114 | 2 | 14982882 | ||
| Pubmed | 2.21e-04 | 7 | 114 | 2 | 11287610 | ||
| Pubmed | 2.21e-04 | 7 | 114 | 2 | 12444928 | ||
| Pubmed | Interaction of the v-Rel oncoprotein with cellular transcription factor Sp1. | 2.21e-04 | 7 | 114 | 2 | 7933095 | |
| Pubmed | Suppression of bone formation by osteoclastic expression of semaphorin 4D. | 2.21e-04 | 7 | 114 | 2 | 22019888 | |
| Pubmed | 2.21e-04 | 7 | 114 | 2 | 22833210 | ||
| Pubmed | 2.94e-04 | 8 | 114 | 2 | 23452850 | ||
| Pubmed | A Conserved Role for Girdin in Basal Body Positioning and Ciliogenesis. | 2.94e-04 | 8 | 114 | 2 | 27623382 | |
| Pubmed | 2.94e-04 | 8 | 114 | 2 | 9344843 | ||
| Pubmed | 2.94e-04 | 8 | 114 | 2 | 15611085 | ||
| Pubmed | 2.94e-04 | 8 | 114 | 2 | 11453982 | ||
| Pubmed | 2.94e-04 | 8 | 114 | 2 | 20473329 | ||
| Pubmed | 3.10e-04 | 40 | 114 | 3 | 25275127 | ||
| Pubmed | 3.50e-04 | 101 | 114 | 4 | 26949739 | ||
| Pubmed | 3.63e-04 | 102 | 114 | 4 | 11214970 | ||
| Pubmed | Genome-wide CRISPR screen identifies HNRNPL as a prostate cancer dependency regulating RNA splicing. | GABRE ATF7 EVL SEMA4D TRIOBP FBXL17 DENND2B EXD3 PWWP2B NFATC1 KDM2A RERE LZTS2 CROCC | 3.75e-04 | 1489 | 114 | 14 | 28611215 |
| Pubmed | Role of ERK1/2 signaling in congenital valve malformations in Noonan syndrome. | 3.78e-04 | 9 | 114 | 2 | 19017799 | |
| Pubmed | 3.91e-04 | 104 | 114 | 4 | 9205841 | ||
| Pubmed | 4.01e-04 | 407 | 114 | 7 | 12693553 | ||
| Pubmed | 4.71e-04 | 10 | 114 | 2 | 9756944 | ||
| Pubmed | Gab1 is an integrator of cell death versus cell survival signals in oxidative stress. | 4.71e-04 | 10 | 114 | 2 | 12808090 | |
| Pubmed | 4.71e-04 | 10 | 114 | 2 | 9632636 | ||
| Pubmed | A central chaperone-like role for 14-3-3 proteins in human cells. | CARMIL2 SASH1 NCKIPSD DENND2B RUSC2 VPS13D EIF4G1 SEC16A SSH2 MEX3B | 5.51e-04 | 861 | 114 | 10 | 36931259 |
| Pubmed | 5.75e-04 | 11 | 114 | 2 | 31585087 | ||
| Pubmed | 5.75e-04 | 11 | 114 | 2 | 10464310 | ||
| Pubmed | VEGF receptor 2 (KDR) protects airways from mucus metaplasia through a Sox9-dependent pathway. | 5.75e-04 | 11 | 114 | 2 | 34010630 | |
| Pubmed | 6.45e-04 | 209 | 114 | 5 | 36779422 | ||
| Pubmed | SHC1 TRIOBP GPRIN3 PPM1J PTPN11 SLC4A1AP ARL13B SEC16A SSH2 LZTS2 FOXC1 | 6.79e-04 | 1049 | 114 | 11 | 27880917 | |
| Pubmed | 6.88e-04 | 12 | 114 | 2 | 25456498 | ||
| Pubmed | 6.88e-04 | 12 | 114 | 2 | 15342473 | ||
| Pubmed | Phosphorylation-dependent binding of 14-3-3 terminates signalling by the Gab2 docking protein. | 6.88e-04 | 12 | 114 | 2 | 19172738 | |
| Pubmed | 6.88e-04 | 12 | 114 | 2 | 30061196 | ||
| Pubmed | 7.55e-04 | 591 | 114 | 8 | 15231748 | ||
| Pubmed | 7.82e-04 | 125 | 114 | 4 | 29467281 | ||
| Pubmed | 8.13e-04 | 332 | 114 | 6 | 37433992 | ||
| Pubmed | 8.38e-04 | 56 | 114 | 3 | 22745667 | ||
| Pubmed | Characterization of cDNA clones in size-fractionated cDNA libraries from human brain. | 8.38e-04 | 56 | 114 | 3 | 9455484 | |
| Pubmed | 8.98e-04 | 225 | 114 | 5 | 12168954 | ||
| Pubmed | Class III myosins shape the auditory hair bundles by limiting microvilli and stereocilia growth. | 9.45e-04 | 14 | 114 | 2 | 26754646 | |
| Pubmed | Hindbrain rhombic lip is comprised of discrete progenitor cell populations allocated by Pax6. | 9.45e-04 | 14 | 114 | 2 | 16364898 | |
| Pubmed | Protein partners in the life history of activated fibroblast growth factor receptors. | 9.75e-04 | 59 | 114 | 3 | 18022941 | |
| Pubmed | Large-scale characterization of HeLa cell nuclear phosphoproteins. | 1.04e-03 | 774 | 114 | 9 | 15302935 | |
| Pubmed | 1.09e-03 | 15 | 114 | 2 | 38517430 | ||
| Pubmed | 1.09e-03 | 15 | 114 | 2 | 10790433 | ||
| Pubmed | 1.09e-03 | 15 | 114 | 2 | 22340494 | ||
| Pubmed | 1.09e-03 | 15 | 114 | 2 | 18639653 | ||
| Pubmed | H4K20me0 recognition by BRCA1-BARD1 directs homologous recombination to sister chromatids. | ATF7 TREX1 TMEM201 ZBTB17 RNF40 E4F1 PALB2 BAZ2A SUPT7L TONSL KDM2A FOXC1 | 1.13e-03 | 1294 | 114 | 12 | 30804502 |
| Pubmed | 1.24e-03 | 16 | 114 | 2 | 32501282 | ||
| Interaction | TOP3B interactions | VWA5B2 SHC1 TRMT1 RNF40 GRIN2D MBD6 FHIP1B PLEKHG5 PLEKHH3 KCNH3 HOXB4 ARHGEF40 PWWP2B AATK NFATC1 ZNF408 NFKB2 EIF4G1 SNX8 SEC16A TP53I13 SECISBP2 DISP2 MEX3B SOWAHB ARHGAP33 | 8.02e-08 | 1470 | 111 | 26 | int:TOP3B |
| Cytoband | Ensembl 112 genes in cytogenetic band chr1p36 | 3.12e-04 | 681 | 114 | 8 | chr1p36 | |
| Cytoband | 1p36.13 | 3.76e-04 | 56 | 114 | 3 | 1p36.13 | |
| Cytoband | 9q22.2 | 8.11e-04 | 17 | 114 | 2 | 9q22.2 | |
| GeneFamily | SH2 domain containing | 9.53e-04 | 101 | 78 | 4 | 741 | |
| GeneFamily | Zinc fingers CXXC-type|Methyl-CpG binding domain containing | 9.85e-04 | 11 | 78 | 2 | 1025 | |
| GeneFamily | Pleckstrin homology domain containing|Rho guanine nucleotide exchange factors|C2 domain containing | 1.97e-03 | 206 | 78 | 5 | 682 | |
| Coexpression | MOREAUX_B_LYMPHOCYTE_MATURATION_BY_TACI_UP | 2.25e-06 | 87 | 114 | 6 | M945 | |
| Coexpression | GSE2405_S_AUREUS_VS_A_PHAGOCYTOPHILUM_NEUTROPHIL_DN | 2.75e-06 | 200 | 114 | 8 | M6208 | |
| Coexpression | RIZ_ERYTHROID_DIFFERENTIATION_6HR | 2.23e-05 | 38 | 114 | 4 | M1854 | |
| Coexpression | RIZ_ERYTHROID_DIFFERENTIATION_6HR | 2.23e-05 | 38 | 114 | 4 | MM512 | |
| Coexpression | GSE369_IFNG_KO_VS_WT_LIVER_UP | 2.71e-05 | 199 | 114 | 7 | M5970 | |
| Coexpression | GSE43863_TH1_VS_TFH_MEMORY_CD4_TCELL_DN | 2.80e-05 | 200 | 114 | 7 | M9735 | |
| Coexpression | MOREAUX_MULTIPLE_MYELOMA_BY_TACI_UP | 4.03e-05 | 376 | 114 | 9 | M19025 | |
| ToppCell | COVID-19-Heart-Fib_+_EC_+_Pericyte|Heart / Disease (COVID-19 only), tissue and cell type | 6.46e-07 | 192 | 114 | 7 | 60b1312e84f6d6448365a952469c506c00b5fe93 | |
| ToppCell | Anterior_Cingulate_gyrus_(CgG)-Neuronal-Inh_GABAergic-i_Gaba_3|Anterior_Cingulate_gyrus_(CgG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 6.69e-07 | 193 | 114 | 7 | 5581a5ebcd21a2a8062ccfb917f088ec67a10a9c | |
| ToppCell | LPS_IL1RA-Mesenchymal_fibroblastic-Fibroblasts-Activated_MatrixFB|LPS_IL1RA / Treatment groups by lineage, cell group, cell type | 8.22e-07 | 199 | 114 | 7 | 8b86c69aaf60feff53aa782559cfece7342a23de | |
| ToppCell | Striatum-Neuronal-Inhibitory|Striatum / BrainAtlas - Mouse McCarroll V32 | 3.21e-06 | 157 | 114 | 6 | c41ff3fe9de7187575114febfe9bd8733366fb8a | |
| ToppCell | droplet-Marrow-nan-24m-Lymphocytic-NK_cell|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.74e-06 | 168 | 114 | 6 | e979a4fbeb9f21048b47d69e6da75c57650697f2 | |
| ToppCell | 343B-Lymphocytic-CD8+_Cytotoxic_T-cell-CD8+_Cytotoxic_T_cell_1|Lymphocytic / Donor, Lineage, Cell class and subclass (all cells) | 5.42e-06 | 172 | 114 | 6 | d65ffff3e341af34a043a0d802d7ba4b69de36e9 | |
| ToppCell | facs-Lung-3m-Mesenchymal-fibroblast-adventitial_fibroblast-adventitial_fibroblast_l17|3m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 7.03e-06 | 180 | 114 | 6 | 39ae8586efd91536e9ac6408d26de7e6d6237c41 | |
| ToppCell | Globus_pallidus-Neuronal-Inhibitory|Globus_pallidus / BrainAtlas - Mouse McCarroll V32 | 7.49e-06 | 182 | 114 | 6 | 04ccfa951eaa31fed6d140edb6c702d49363c5fa | |
| ToppCell | COVID-19-Heart-Fib_1|COVID-19 / Disease (COVID-19 only), tissue and cell type | 9.01e-06 | 188 | 114 | 6 | fe361215f4ba841aa5e1e581fb56f2f4d3ccd201 | |
| ToppCell | Primary_Motor_Cortex_(M1)-Neuronal-Inh_GABAergic-i_Gaba_3-GABA_PVALB_1|Primary_Motor_Cortex_(M1) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 9.01e-06 | 188 | 114 | 6 | 8de5a07301f9b5984680c873e5a92395b5ed3dd3 | |
| ToppCell | Primary_Motor_Cortex_(M1)-Neuronal-Inh_GABAergic-i_Gaba_3|Primary_Motor_Cortex_(M1) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 9.57e-06 | 190 | 114 | 6 | d19bc44310c53726e2f5f6a2bd377bbbf1d1983f | |
| ToppCell | droplet-Kidney-KIDNEY-30m-Epithelial-podocyte|Kidney / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 9.57e-06 | 190 | 114 | 6 | 050d6e0546954675b6adbfecb67854b1e09739d1 | |
| ToppCell | 5'-Adult-LymphNode-Endothelial-lymphatic_endothelial|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 9.57e-06 | 190 | 114 | 6 | 6b704deeb44e1ffa10e604d0e5612b022f6cd9a6 | |
| ToppCell | TCGA-Prostate-Primary_Tumor-Prostate_Adenocarcinoma-Acinar_Adenocarcinoma-4|TCGA-Prostate / Sample_Type by Project: Shred V9 | 1.11e-05 | 195 | 114 | 6 | 5562665dd3beb70e2358aa32611a337bef5731c1 | |
| ToppCell | facs-Skin-nan-18m-Epithelial-outer_bulge|Skin / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.11e-05 | 195 | 114 | 6 | ba7cb80deb872c9184769f0dd57855c3c6a432bf | |
| ToppCell | saliva-Severe-critical_progression_d12-22_no-steroids-Epithelial|Severe-critical_progression_d12-22_no-steroids / Compartment, severity and other cell annotations on 10x 3' data (130k) | 1.21e-05 | 198 | 114 | 6 | fb3965049cb1961de0d2e74370868e46aa5050c8 | |
| ToppCell | saliva-Severe-critical_progression_d12-22_no-steroids-Epithelial-Epithelial,_Airway-squamous_epithelial_cell-Epi-Squamous|Severe-critical_progression_d12-22_no-steroids / Compartment, severity and other cell annotations on 10x 3' data (130k) | 1.21e-05 | 198 | 114 | 6 | 72d91bd0c727ecadc41e023a16c9326158db1b7b | |
| ToppCell | Fibroblasts-HLA-DRA_high_Fibroblasts|World / Immune cells in Rheumatoid Arthritis Joint Synovial Tissues | 1.21e-05 | 198 | 114 | 6 | e8c0fbf306fae13e97caa294d7c99a564bd97130 | |
| ToppCell | saliva-Severe-critical_progression_d12-22_no-steroids-Epithelial-Epithelial,_Airway-squamous_epithelial_cell|Severe-critical_progression_d12-22_no-steroids / Compartment, severity and other cell annotations on 10x 3' data (130k) | 1.21e-05 | 198 | 114 | 6 | 441608034c787e55691558a480dcd07e37419138 | |
| ToppCell | saliva-Severe-critical_progression_d12-22_no-steroids-Epithelial-Epithelial,_Airway|Severe-critical_progression_d12-22_no-steroids / Compartment, severity and other cell annotations on 10x 3' data (130k) | 1.21e-05 | 198 | 114 | 6 | 9f5726aedd1fb132feab717a029fa302306461b5 | |
| ToppCell | 10x_5'_v1-Non-neoplastic-Glial-Neuronal-Oligodendrocyte-Oligodendrocyte|10x_5'_v1 / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 1.25e-05 | 199 | 114 | 6 | 5d2e85e40b6b52b1809e680b952913d77215b3d0 | |
| ToppCell | 10x_5'_v1-Non-neoplastic-Glial-Neuronal-Oligodendrocyte|10x_5'_v1 / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 1.25e-05 | 199 | 114 | 6 | 9dd4b17fb8c70ab9e126b23b72600463f3db832d | |
| ToppCell | 10x_5'_v1-Non-neoplastic-Glial-Neuronal-Oligodendrocyte-Oligodendrocyte-Z|10x_5'_v1 / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 1.25e-05 | 199 | 114 | 6 | 6fb5f931e6217142de38c1fffc011e63bda4772b | |
| ToppCell | 10x_5'_v1-Non-neoplastic-Glial-Neuronal|10x_5'_v1 / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 1.25e-05 | 199 | 114 | 6 | 1bb5797e8e0552bf9b44bf4c958d1aa6dbe6c756 | |
| ToppCell | Striatum-Neuronal-Inhibitory-iN1(Gad1Gad2_Th)|Striatum / BrainAtlas - Mouse McCarroll V32 | 2.37e-05 | 133 | 114 | 5 | d5326a6ccada5ae6d3e8f7d4a858c90050e23c5b | |
| ToppCell | PND03-Immune-Immune_Myeloid-Granulocytic-Neutrophil-Neutrophil_prolif|PND03 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 4.64e-05 | 153 | 114 | 5 | 489228ab81c3ae339a53a9da6c2a1c1b6ac3f84b | |
| ToppCell | primary_visual_cortex-Neuronal-glutamatergic_neuron-L6b-L6b_Hsd17b2|primary_visual_cortex / Per Region, Lineage, Cell class, Cell type, Cell subtype | 4.83e-05 | 78 | 114 | 4 | e5dbb0986cbee58fb1e5e464a3b003c4136246e7 | |
| ToppCell | renal_medulla_nuclei-Hypertensive_with+without-CKD-Endothelial-blood_vessel_endothelial_cell_of_kidney-arteriolar_vasa-recta_endothelial-Ascending_Vasa_Recta_Endothelial_Cell_prolif|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 4.94e-05 | 155 | 114 | 5 | babcb9e548f04ace8157d506d27c5941c692c491 | |
| ToppCell | TCGA-Breast-Primary_Tumor-Breast_Carcinoma-Infiltrating_Lobular_Carcinoma|TCGA-Breast / Sample_Type by Project: Shred V9 | 4.94e-05 | 155 | 114 | 5 | a4f2fffa8d0de760c556c3f8f1c91804eedbfa68 | |
| ToppCell | facs-Marrow-KLS-18m-Myeloid-CD4+_macrophage|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 5.25e-05 | 157 | 114 | 5 | 5d08ff0ba9d3df9cc30f13cab2d2b395ea6f3446 | |
| ToppCell | Control-Endothelial-Epi-like|Control / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 5.25e-05 | 157 | 114 | 5 | 4d02c50d5d1b892ea241e98724386d8a5a156a46 | |
| ToppCell | facs-Marrow-KLS-18m-Myeloid-macrophage|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 5.25e-05 | 157 | 114 | 5 | ad9c9b7dfeee3ae46e7e593c51a0407df12195b4 | |
| ToppCell | Control-Endothelial-Epi-like-Alv_Cap|Control / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 5.25e-05 | 157 | 114 | 5 | 2c369660c752c0fb3bd798a561d3359e2f9aa983 | |
| ToppCell | TCGA-Bladder-Primary_Tumor-Urothelial_Carcinoma-Papillary_Muscle_Invasive_Urothelial_Carcinoma|TCGA-Bladder / Sample_Type by Project: Shred V9 | 5.41e-05 | 158 | 114 | 5 | dc559503bab3ec1b9ea54ef2e896d1be33e5344c | |
| ToppCell | TCGA-Liver-Primary_Tumor-Hepatocellular_Carcinoma-Hepatocellular_Carcinoma-6|TCGA-Liver / Sample_Type by Project: Shred V9 | 7.43e-05 | 169 | 114 | 5 | e992530776cab922d0360b275fb9cb8bd0017b06 | |
| ToppCell | normal_Pleural_Fluid-Myeloid_cells-CD1c+_DCs|normal_Pleural_Fluid / Location, Cell class and cell subclass | 8.08e-05 | 172 | 114 | 5 | 200b2e63313b110b8ca59ee5b72c02cc8ed907cd | |
| ToppCell | Globus_pallidus-Neuronal-Inhibitory-iN1(Gad1Gad2_Th)|Globus_pallidus / BrainAtlas - Mouse McCarroll V32 | 8.30e-05 | 173 | 114 | 5 | 7e3897868dd3f6e4974f593c60649a543ffc8693 | |
| ToppCell | facs-Marrow-KLS-3m-Lymphocytic-immature_B_cell|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 8.30e-05 | 173 | 114 | 5 | 8bffd512a4e561e23cc04478e2ca6fd5d3771fe4 | |
| ToppCell | facs-Marrow-KLS-3m-Lymphocytic-immature_B_cell|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 8.30e-05 | 173 | 114 | 5 | 3e3c61468e703330788a10d850ef41a85680f86d | |
| ToppCell | 5'-Airway_Nasal-Epithelial-Epithelial_transtional-secretory-club_cell-Club_(non-nasal)|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 8.53e-05 | 174 | 114 | 5 | 42f2ba54b4ea4c62482582b0ccdadffae0a5eb4a | |
| ToppCell | renal_medulla_nuclei-Hypertensive_with+without-CKD-Epithelial-Intermediate_tubule_epithelial_cell-kidney_loop_of_Henle_thin_descending_limb_epithelial_cell|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 9.00e-05 | 176 | 114 | 5 | 327a3e81b724252e36d786de92a3ffd721ea6d7b | |
| ToppCell | renal_medulla_nuclei-Hypertensive_with+without-CKD-Epithelial-Intermediate_tubule_epithelial_cell-kidney_loop_of_Henle_thin_descending_limb_epithelial_cell-Descending_Thin_Limb_Cell_Type_1|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 9.24e-05 | 177 | 114 | 5 | da8802a6351d3e510822f82e2fde8a4314a2216e | |
| ToppCell | 3'-Parenchyma_lung-Endothelial-Lymphatic_EC-endothelial_cell_of_lymphatic_vessel-Lymphatic_EC_differentiating-Lymphatic_EC_differentiating_L.2.5.1.1|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 9.49e-05 | 178 | 114 | 5 | ad3de3e03a401dac64431a541899445262246347 | |
| ToppCell | T_cells-TFH-like_cells|T_cells / Immune cells in Kidney/Urine in Lupus Nephritis | 9.49e-05 | 178 | 114 | 5 | e2ae43e5ec31de6197f2cbd6089f944adbf0a163 | |
| ToppCell | 5'-Adult-LymphNode-Endothelial-lymphatic_endothelial-LEC6_(ADAMTS4+)|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 9.75e-05 | 179 | 114 | 5 | 9fd9b136ecbcbd4e4f0d5875ede98d8d48608afb | |
| ToppCell | Primary_Motor_Cortex_(M1)-Neuronal-Inh_GABAergic-i_Gaba_3-GABA_PVALB_1-Inh_L5-6_PVALB_STON2|Primary_Motor_Cortex_(M1) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 9.75e-05 | 179 | 114 | 5 | d1365d48d1b017a7917f4f63a82ac4720c3d87df | |
| ToppCell | Endothelial-B-IPF_02|World / lung cells shred on cell class, cell subclass, sample id | 1.03e-04 | 181 | 114 | 5 | 4fe0215d08f03d4e24749d70fce01b7aa22906fd | |
| ToppCell | renal_medulla_nuclei-Adult_normal_reference-Epithelial-Intermediate_tubule_epithelial_cell-kidney_loop_of_Henle_thin_descending_limb_epithelial_cell-Descending_Thin_Limb_Cell_Type_1|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 1.03e-04 | 181 | 114 | 5 | 071f9bb5d39070cdc473d9b0e094d196bc702b56 | |
| ToppCell | renal_medulla_nuclei-Adult_normal_reference-Epithelial-Intermediate_tubule_epithelial_cell-kidney_loop_of_Henle_thin_descending_limb_epithelial_cell|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 1.08e-04 | 183 | 114 | 5 | 738e94b50c4c08c727d4eed0708dda08aa6891b4 | |
| ToppCell | 5'-Adult-LymphNode-Endothelial-lymphatic_endothelial-LEC1_(ACKR4+)|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 1.08e-04 | 183 | 114 | 5 | 2d0d3b486498a7903fa9a1f48b189291da49c430 | |
| ToppCell | renal_medulla_nuclei-Renal_AKI_(acute_kidney_injury)-Epithelial-Intermediate_tubule_epithelial_cell-kidney_loop_of_Henle_thin_descending_limb_epithelial_cell-Descending_Thin_Limb_Cell_Type_1|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 1.11e-04 | 184 | 114 | 5 | da06ff24ee2b2cf4715fdfce43030b2da9e0aaf8 | |
| ToppCell | 5'-Adult-Distal_Rectal-Mesenchymal-fibroblastic-mLN_Stroma_(FMO2+)|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 1.14e-04 | 185 | 114 | 5 | 9faa35ceb89ccd2979072286f063687c9f846ce3 | |
| ToppCell | droplet-Lung-nan-3m-Endothelial-endothelial_cell_of_lymphatic_vessel|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.14e-04 | 185 | 114 | 5 | 6a85399cfdb9b89683c874e7f046957f9a601dc2 | |
| ToppCell | Endothelial-B-Donor_07|World / lung cells shred on cell class, cell subclass, sample id | 1.14e-04 | 185 | 114 | 5 | 133c9dc64d564dae4aeeeca22f386aa3f13fa980 | |
| ToppCell | droplet-Lung-nan-3m-Endothelial-Lymphatic_endothelial_cell|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.14e-04 | 185 | 114 | 5 | 64791056cdbb739136dbef08f4b16e2b5427faad | |
| ToppCell | Smart-start-Cell-Wel_seq-Non-neoplastic-Endothelial-Endothelial_immature-Tip-like-G|Smart-start-Cell-Wel_seq / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 1.17e-04 | 186 | 114 | 5 | a906020a8df6fcca474b278f746c553b177a56b4 | |
| ToppCell | 3'-Parenchyma_lung-Endothelial-Lymphatic_EC-endothelial_cell_of_lymphatic_vessel-Lymphatic_EC_differentiating|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 1.17e-04 | 186 | 114 | 5 | 20340a5b5cc7f07386498a4ef937d6fbc9e347c4 | |
| ToppCell | droplet-Lung-1m-Mesenchymal-fibroblast-adventitial_fibroblast-adventitial_fibroblast_l17|1m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 1.20e-04 | 187 | 114 | 5 | ed7ab4cf4629d96dad5c74d536fc428d0a8d4eb9 | |
| ToppCell | kidney_cells-Hypertensive_with+without-CKD-Endothelial-lymphatic_endothelial_cell|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 1.20e-04 | 187 | 114 | 5 | 65d406122dffe18279f14a1ed35ba091730b97be | |
| ToppCell | kidney_cells-Hypertensive_with+without-CKD-Endothelial-lymphatic_endothelial_cell-lymphatic_endothelial_cell_of_renal_cortex-lymphatic_endothelial_cell_of_renal_cortex|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 1.20e-04 | 187 | 114 | 5 | 4c15c0ed41a55271fc793cb76fee97fa64190369 | |
| ToppCell | 5'-Airway_Nasal-Epithelial-Epithelial_transtional-secretory-club_cell-Club_(non-nasal)-Club_(non-nasal)_L.0.4.0.1|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 1.20e-04 | 187 | 114 | 5 | f5a202d5f8eb57b57d80815ce98774e04c387383 | |
| ToppCell | kidney_cells-Hypertensive_with+without-CKD-Endothelial-lymphatic_endothelial_cell-lymphatic_endothelial_cell_of_renal_cortex|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 1.20e-04 | 187 | 114 | 5 | 5274f2b302bbf7fed30c480af4f35058d2cf61e0 | |
| ToppCell | TCGA-Colorectal-Primary_Tumor-Colorectal_Adenocarcinoma-Colon_Adenocarcinoma-7|TCGA-Colorectal / Sample_Type by Project: Shred V9 | 1.23e-04 | 188 | 114 | 5 | 14bc73cf79c79c9f208369fd8d498e5b26e0114d | |
| ToppCell | 10x3'2.3-week_14-16-Mesenchymal_myocytic-stroma-muscle_stem_cell|week_14-16 / cell types per 3 fetal stages;per 3',per 5' | 1.23e-04 | 188 | 114 | 5 | de6f4889e0c5f39fbbaefd85526f645c6afa09d5 | |
| ToppCell | renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Mesenchymal-Fibroblast-high_collagen-matrisome_fibroblast|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 1.26e-04 | 189 | 114 | 5 | 71397e993a77d70b2eeede240bdfc7660b558987 | |
| ToppCell | droplet-Lung-LUNG-1m-Mesenchymal-adventitial_cell|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.26e-04 | 189 | 114 | 5 | f0a2d4ef9896d764971ebbc6952510c128bb76e8 | |
| ToppCell | renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Mesenchymal-Fibroblast-high_collagen-matrisome_fibroblast-|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 1.26e-04 | 189 | 114 | 5 | 4eea4759520c312bd17a681034d8074e47093d2b | |
| ToppCell | 10x_3'_v2v3-Non-neoplastic-Endothelial-Endothelial_mature-Endo_capilar-C|10x_3'_v2v3 / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 1.26e-04 | 189 | 114 | 5 | f44ddb6cdbb406b0528a9b0ba3811183ab6d1fc6 | |
| ToppCell | droplet-Lung-LUNG-1m-Mesenchymal-Adventitial_Fibroblast|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.26e-04 | 189 | 114 | 5 | 378f26f751ab4b470948c35dd8347de72dd12ff7 | |
| ToppCell | PND01-Mesenchymal-Mesenchymal_structural-Fibroblastic-AF2-AF2_mature|PND01 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 1.29e-04 | 190 | 114 | 5 | 947807863a9b247c301c6cf63d6fd5a2c8018e66 | |
| ToppCell | Somatosensory_Cortex_(S1)-Neuronal-Inh_GABAergic-i_Gaba_3-GABA_PVALB_1|Somatosensory_Cortex_(S1) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 1.29e-04 | 190 | 114 | 5 | 3f22c118d552345f731d4d49f0bcb5765d93de3b | |
| ToppCell | human_hepatoblastoma-Endothelial_cells|World / Sample and Cell Type and Tumor Cluster (all cells) | 1.29e-04 | 190 | 114 | 5 | 8d6ef93d69e96cd6921816d152bea3b0710cf147 | |
| ToppCell | (1)_T_cells-(1)_T_CD4_fh|(1)_T_cells / Spleen cell shreds - cell class (v1) and cell subclass (v1) | 1.29e-04 | 190 | 114 | 5 | 120ca702600373c208a3d032fede0a040736e5cf | |
| ToppCell | Fetal_29-31_weeks-Mesenchymal-matrix_fibroblast_2_cell-D088|Fetal_29-31_weeks / Lineage, Cell type, age group and donor | 1.29e-04 | 190 | 114 | 5 | 0fea33f2dc1efa23aaa2da1c318482a52a313ff1 | |
| ToppCell | renal_medulla_nuclei-Hypertensive_with+without-CKD-Mesenchymal-Fibroblast-Collagen+matrisome-high_fibroblast|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 1.32e-04 | 191 | 114 | 5 | a6c57627077fa980b7ec1d3894b5f31bfb11b738 | |
| ToppCell | PND01-Mesenchymal-Mesenchymal_structural-Fibroblastic-AF2|PND01 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 1.32e-04 | 191 | 114 | 5 | db4943dd19207663fb9e27f8940fa4b06a933625 | |
| ToppCell | renal_medulla_nuclei-Hypertensive_with+without-CKD-Mesenchymal-Fibroblast-Collagen+matrisome-high_fibroblast-|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 1.32e-04 | 191 | 114 | 5 | 8f6d592edc32fdb901af30501d4360512334e8c2 | |
| ToppCell | facs-Pancreas-Exocrine-3m-Mesenchymal-pancreatic_stellate_cell|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.35e-04 | 192 | 114 | 5 | 8937a59f6bbe07f671bdabbd3707dc9c17a14cd9 | |
| ToppCell | facs-Pancreas-Exocrine-3m-Mesenchymal|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.35e-04 | 192 | 114 | 5 | e4a7f2673f801b008ca67291db2fb2b9fd2955b8 | |
| ToppCell | facs-Pancreas-Exocrine-3m-Mesenchymal-pancreatic_stellate_cell|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.35e-04 | 192 | 114 | 5 | ac1477433704573f95111eee6263b93668d2845e | |
| ToppCell | 5'-Parenchyma_lung-Mesenchymal-Fibroblastic-fibroblastic_type_2-Peribronchial_fibroblasts-Peribronchial_fibroblasts_L.2.1.3.0|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 1.35e-04 | 192 | 114 | 5 | b9e4585bea280ca0ae159f0c6a2bf7b88a15a6e6 | |
| ToppCell | droplet-Lung-1m-Mesenchymal-fibroblast-adventitial_fibroblast|1m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 1.35e-04 | 192 | 114 | 5 | f9fb24457999dc9e751a099d7f995543b9330ad4 | |
| ToppCell | 10x_3'_v2v3-Non-neoplastic-Glial-Neuronal-Oligodendrocyte-Oligodendrocyte-C|10x_3'_v2v3 / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 1.35e-04 | 192 | 114 | 5 | 3ce5dbde41aeb73d49f2c7991d34682f0827fa5a | |
| ToppCell | LAM-Endothelial-LymEndo|LAM / Condition, Lineage and Cell class | 1.39e-04 | 193 | 114 | 5 | 68eadc91c2d89edd2412e86dfe134dd7c0ef6ee9 | |
| ToppCell | Mid-temporal_gyrus_(MTG)-Neuronal-Inh_GABAergic-i_Gaba_3|Mid-temporal_gyrus_(MTG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 1.39e-04 | 193 | 114 | 5 | 53bcd50892c379b2a571751f6eb1062436339fe7 | |
| ToppCell | TCGA-Colorectal-Primary_Tumor-Colorectal_Adenocarcinoma-Colon_Adenocarcinoma-10|TCGA-Colorectal / Sample_Type by Project: Shred V9 | 1.39e-04 | 193 | 114 | 5 | 194e7fa00a50cc4e026987b715323d125d79594e | |
| ToppCell | 5'-Adult-SmallIntestine-Endothelial-lymphatic_endothelial-LEC6_(ADAMTS4+)|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 1.42e-04 | 194 | 114 | 5 | 937ee85ffd50869b60f0f6e91017ab77e8b24c0b | |
| ToppCell | renal_medulla_nuclei-CKD+DKD_normotensive-Mesenchymal-Fibroblast-Collagen-low_Matrisome-low_fibroblast|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 1.42e-04 | 194 | 114 | 5 | 90efdbd7f1c85fd7fd622b10340250b1d8fc1197 | |
| ToppCell | renal_medulla_nuclei-CKD+DKD_normotensive-Mesenchymal-Fibroblast-Collagen-low_Matrisome-low_fibroblast-|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 1.42e-04 | 194 | 114 | 5 | df82cce5ebeb73740b02cf816c6df82253cfd566 | |
| ToppCell | LPS-antiTNF-Stromal_mesenchymal-Matrix_Fibroblast-Activated_MatrixFB|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 1.42e-04 | 194 | 114 | 5 | 89b706af2b25991fc2707eb24f49ba6ff3ae01f7 | |
| ToppCell | COVID-19-Heart-Fib_1|Heart / Disease (COVID-19 only), tissue and cell type | 1.45e-04 | 195 | 114 | 5 | f423baa36ac7cdc383c033e35a7d17e6bf913323 | |
| ToppCell | 3'-Adult-LymphNode-Endothelial-lymphatic_endothelial|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 1.49e-04 | 196 | 114 | 5 | a2845436003e9adf34677eb81e78f8334ff01faa | |
| ToppCell | 3'-Adult-LymphNode-Endothelial-lymphatic_endothelial-LEC1_(ACKR4+)|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 1.49e-04 | 196 | 114 | 5 | aa52f77f80c3fe23369347a34e0b3188b768a763 | |
| ToppCell | renal_cortex_nuclei-CKD+DKD_normotensive-Mesenchymal-Fibroblast-Collagen+matrisome-high_fibroblast-|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 1.53e-04 | 197 | 114 | 5 | 85a8f1d18e0dd1d31341f5131eecd217553bf042 | |
| ToppCell | critical-Epithelial-Squamous|critical / Severity, Lineage and Cell class of Nasopharyngeal (NS) Samples from Patients and Controls | 1.53e-04 | 197 | 114 | 5 | eccc80d6ab79c46b10108de1cff3abeacfc105cd | |
| ToppCell | renal_cortex_nuclei-CKD+DKD_normotensive-Mesenchymal-Fibroblast-Collagen+matrisome-high_fibroblast|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 1.53e-04 | 197 | 114 | 5 | e8e3ba791dfaa0fab35e0329a5e34376f9ee6143 | |
| ToppCell | 5'-Adult-SmallIntestine-Endothelial-lymphatic_endothelial|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 1.53e-04 | 197 | 114 | 5 | 407231542fa1ffd540dcb61435c0575e71f59725 | |
| ToppCell | Smart-start-Cell-Wel_seq-Non-neoplastic-Endothelial-Endothelial_mature|Smart-start-Cell-Wel_seq / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 1.56e-04 | 198 | 114 | 5 | 218f33e068eb126458ec33176de3cfa6fc06ddf0 | |
| ToppCell | 5'-Adult-LymphNode-Endothelial|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 1.56e-04 | 198 | 114 | 5 | d7e15e61b6018e4c36461c9471ee29601929925c | |
| ToppCell | LPS_IL1RA-Mesenchymal_fibroblastic-Fibroblasts|LPS_IL1RA / Treatment groups by lineage, cell group, cell type | 1.60e-04 | 199 | 114 | 5 | ba586690f88fd051f449753bfe7603a2cb431782 | |
| Drug | Methiazole; Down 200; 15uM; PC3; HT_HG-U133A | 6.71e-07 | 197 | 114 | 9 | 4532_DN | |
| Drug | leflunomide | 4.37e-06 | 85 | 114 | 6 | CID000003899 | |
| Drug | Ascorbic acid [50-81-7]; Up 200; 22.4uM; MCF7; HT_HG-U133A | 6.60e-06 | 196 | 114 | 8 | 5407_UP | |
| Drug | Homatropine hydrobromide (R,S) [51-56-9]; Up 200; 11.2uM; MCF7; HT_HG-U133A | 7.11e-06 | 198 | 114 | 8 | 5477_UP | |
| Drug | Methimazole [60-56-0]; Down 200; 35uM; PC3; HT_HG-U133A | 7.11e-06 | 198 | 114 | 8 | 4550_DN | |
| Drug | Brompheniramine maleate [980-71-2]; Down 200; 9.2uM; MCF7; HT_HG-U133A | 7.11e-06 | 198 | 114 | 8 | 4131_DN | |
| Drug | Zoxazolamine [61-80-3]; Up 200; 23.8uM; MCF7; HT_HG-U133A | 7.38e-06 | 199 | 114 | 8 | 2625_UP | |
| Drug | Propofol [2078-54-8]; Up 200; 22.4uM; MCF7; HT_HG-U133A | 4.42e-05 | 187 | 114 | 7 | 3386_UP | |
| Drug | troglitazone; Down 200; 10uM; PC3; HT_HG-U133A | 4.57e-05 | 188 | 114 | 7 | 4456_DN | |
| Drug | 2-deoxy-D-glucose; Down 200; 10000uM; MCF7; HG-U133A | 5.58e-05 | 194 | 114 | 7 | 344_DN | |
| Drug | 0317956-0000 [391210-11-0]; Down 200; 1uM; MCF7; HT_HG-U133A | 5.58e-05 | 194 | 114 | 7 | 3969_DN | |
| Drug | Acetaminophen [103-90-2]; Down 200; 26.4uM; MCF7; HT_HG-U133A | 5.58e-05 | 194 | 114 | 7 | 5384_DN | |
| Drug | PF-00562151-00 [351320-12-2]; Up 200; 10uM; MCF7; HT_HG-U133A | 5.58e-05 | 194 | 114 | 7 | 5954_UP | |
| Drug | Isosorbide dinitrate [87-33-2]; Down 200; 17uM; MCF7; HT_HG-U133A | 5.77e-05 | 195 | 114 | 7 | 4742_DN | |
| Drug | Amphotericin B [1397-89-3]; Up 200; 4.4uM; PC3; HT_HG-U133A | 5.77e-05 | 195 | 114 | 7 | 6303_UP | |
| Drug | chlorpromazine hydrochloride; Up 200; 1uM; MCF7; HT_HG-U133A | 5.95e-05 | 196 | 114 | 7 | 5577_UP | |
| Drug | Epicatechin-(-) [154-23-4]; Down 200; 13.8uM; PC3; HT_HG-U133A | 5.95e-05 | 196 | 114 | 7 | 4594_DN | |
| Drug | 0173570-0000 [211245-44-2]; Up 200; 10uM; PC3; HT_HG-U133A | 5.95e-05 | 196 | 114 | 7 | 3690_UP | |
| Drug | Diphemanil methylsulfate [62-97-5]; Down 200; 10.2uM; PC3; HT_HG-U133A | 5.95e-05 | 196 | 114 | 7 | 4591_DN | |
| Drug | Lobeline alpha (-) hydrochoride [134-63-4]; Up 200; 10.6uM; HL60; HG-U133A | 5.95e-05 | 196 | 114 | 7 | 1770_UP | |
| Drug | Chlorzoxazone [95-25-0]; Up 200; 23.6uM; HL60; HG-U133A | 5.95e-05 | 196 | 114 | 7 | 1416_UP | |
| Drug | Vitamin K2 [11032-49-8]; Up 200; 9uM; PC3; HT_HG-U133A | 6.15e-05 | 197 | 114 | 7 | 3798_UP | |
| Drug | Mianserine hydrochloride [21535-47-7]; Down 200; 13.2uM; PC3; HT_HG-U133A | 6.35e-05 | 198 | 114 | 7 | 2068_DN | |
| Drug | Meclofenamic acid sodium salt monohydrate [6385-02-0]; Up 200; 11.8uM; PC3; HT_HG-U133A | 6.35e-05 | 198 | 114 | 7 | 7280_UP | |
| Drug | 2-propylpentanoic acid; Up 200; 200uM; MCF7; HT_HG-U133A | 6.35e-05 | 198 | 114 | 7 | 5211_UP | |
| Drug | Paromomycin sulfate [1263-89-4]; Up 200; 5.6uM; MCF7; HT_HG-U133A | 6.35e-05 | 198 | 114 | 7 | 3356_UP | |
| Drug | Mebeverine hydrochloride [2753-45-9]; Up 200; 8.6uM; MCF7; HT_HG-U133A | 6.55e-05 | 199 | 114 | 7 | 6795_UP | |
| Drug | Paclitaxel [33069-62-4]; Up 200; 4.6uM; PC3; HG-U133A | 6.55e-05 | 199 | 114 | 7 | 1959_UP | |
| Drug | Coralyne chloride hydrate [38989-38-7]; Up 200; 9.6uM; MCF7; HT_HG-U133A | 6.55e-05 | 199 | 114 | 7 | 2652_UP | |
| Drug | Khellin [82-02-0]; Up 200; 15.4uM; PC3; HG-U133A | 6.76e-05 | 200 | 114 | 7 | 1922_UP | |
| Drug | alpha-estradiol; Up 200; 0.01uM; PC3; HG-U133A | 6.76e-05 | 200 | 114 | 7 | 702_UP | |
| Drug | Tacrine hydrochloride hydrate [1684-40-8]; Up 200; 15.8uM; MCF7; HT_HG-U133A | 6.76e-05 | 200 | 114 | 7 | 2633_UP | |
| Drug | heptachlor epoxide | 8.27e-05 | 46 | 114 | 4 | CID000013930 | |
| Disease | neurotic disorder | 5.46e-04 | 101 | 109 | 4 | EFO_0004257 | |
| Disease | right ventricular stroke volume measurement | 8.71e-04 | 12 | 109 | 2 | EFO_0021817 | |
| Disease | rotator cuff tear | 8.71e-04 | 12 | 109 | 2 | EFO_1001250 | |
| Disease | response to olanzapine | 1.38e-03 | 15 | 109 | 2 | GO_0097333 | |
| Disease | leukemia (implicated_via_orthology) | 2.22e-03 | 19 | 109 | 2 | DOID:1240 (implicated_via_orthology) | |
| Disease | aortic measurement | 2.44e-03 | 251 | 109 | 5 | EFO_0020865 | |
| Disease | glaucoma (is_marker_for) | 2.46e-03 | 20 | 109 | 2 | DOID:1686 (is_marker_for) | |
| Disease | esophagus adenocarcinoma (is_implicated_in) | 2.71e-03 | 21 | 109 | 2 | DOID:4914 (is_implicated_in) | |
| Disease | Joubert syndrome 1 | 2.71e-03 | 21 | 109 | 2 | C4551568 | |
| Disease | gastric ulcer (biomarker_via_orthology) | 2.71e-03 | 21 | 109 | 2 | DOID:10808 (biomarker_via_orthology) | |
| Disease | cortical thickness | VWA5B2 SEMA4D TRIOBP MBD6 BNC1 VPS13D ARHGEF40 CEP120 KIAA1755 RERE SSH2 | 2.76e-03 | 1113 | 109 | 11 | EFO_0004840 |
| Disease | triacylglycerol 58:9 measurement | 2.98e-03 | 22 | 109 | 2 | EFO_0010443 | |
| Disease | R-warfarin measurement | 3.08e-03 | 265 | 109 | 5 | EFO_0803324 | |
| Disease | triacylglycerol 54:8 measurement | 3.25e-03 | 23 | 109 | 2 | EFO_0010426 | |
| Disease | Sjogren's syndrome (is_marker_for) | 3.54e-03 | 24 | 109 | 2 | DOID:12894 (is_marker_for) | |
| Disease | suicidal ideation, suicide behaviour | 3.54e-03 | 24 | 109 | 2 | EFO_0004320, EFO_0007623 | |
| Disease | short-term memory | 3.64e-03 | 83 | 109 | 3 | EFO_0004335 |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| EGPPDSTSTCLPPEP | 731 | Q9Y2J4 | |
| PTCDGTPLPEPGTSE | 131 | O75150 | |
| CPPEEPPPSRDTLNT | 556 | Q8TER5 | |
| PCNAAPTPPPAVSED | 1331 | Q9UIF9 | |
| PGQSPSPCRTSPSPD | 1316 | Q6F5E8 | |
| CSGPVDSECPPPPSS | 251 | Q8N556 | |
| PGFTVTSPDCRPPPS | 441 | Q01954 | |
| CPPSQTGPEEPLEPA | 121 | O96018 | |
| STPEAPDIPACPSPG | 81 | Q9H211 | |
| GSSQGPAPCPAPAPT | 16 | Q9UGL9 | |
| PLNIDDCAPESPTPP | 361 | Q3SXY8 | |
| SSPPDSPASSPCSPP | 116 | P17544 | |
| QDPSPDTSPPTCPFK | 81 | P78524 | |
| PDFTSPSGSCPAPLP | 76 | Q8N5N4 | |
| CPLEDPSSSSGPPPT | 61 | A7MBM2 | |
| PPSECNPALDDPTPD | 21 | Q9Y284 | |
| CESLSGPAPSEPTPG | 146 | Q8NBR0 | |
| SEANGPCPSPIPTPE | 181 | A6NDB9 | |
| GDLCSEPSTPASPPP | 1006 | Q9ULD8 | |
| GPTPDCSPPSPDTAL | 501 | Q7Z6G8 | |
| SPGPAPCSPGLSASP | 516 | Q8N612 | |
| AGSTSGPVPQPACPP | 621 | Q13164 | |
| RPCDPSGPTPSEPSA | 71 | Q9Y278 | |
| DPPSGTPPQPCVLSA | 686 | Q96DN6 | |
| EQPEAPCLPPESPAS | 806 | Q96DN6 | |
| SPDSSSCGERSPPPP | 301 | Q9BRK4 | |
| GPPQSPPQSPLDSCS | 406 | Q8TD91 | |
| PCLPGPPSPASDAES | 171 | Q92886 | |
| CPSRNTSSPEPPTPG | 456 | Q5JYT7 | |
| PPEPGTPANCDPALS | 281 | P08254 | |
| PPSENPPPETGESVC | 111 | Q16342 | |
| SAASAPVSCSGPPPP | 171 | Q9UI08 | |
| PGLEHSLCPSSPSPP | 836 | O95644 | |
| LPGPDPTPSLTGSCP | 656 | Q9UBG0 | |
| PSCSAQQPPSPGSPE | 421 | P78334 | |
| GVDSDCPSTTLPPAP | 4821 | P98088 | |
| DQTSGDQSPLPPCTP | 551 | Q06124 | |
| ASCPTGPPQNPPSSP | 1381 | Q9UKK3 | |
| SSSPEDLCPAPGTPP | 11 | Q14451 | |
| PGQRCEAVSSSPPPP | 106 | P17483 | |
| EAVSSSPPPPPCAQN | 111 | P17483 | |
| DCDSVPPGTPPPIES | 801 | Q86YC2 | |
| GPSPEPTQRPPTICE | 1006 | Q14112 | |
| PSGPGQSQPSPPACE | 121 | P06401 | |
| PCPPPPSASFLSTEC | 1826 | Q96QU1 | |
| RCSSPTPGDPAPPAS | 746 | O14559 | |
| ECSPGSQPPSPGPAT | 1481 | Q5TZA2 | |
| RSCDEPLTPPPHSPT | 706 | Q9Y2K7 | |
| VPCTPASAPTSGPAP | 276 | Q0VDD7 | |
| SCSQGPPSPASPDPK | 176 | Q8N143 | |
| PPTSVGPASPQCPGE | 451 | Q9BWV1 | |
| PESQGPRTPPSPGIC | 2316 | O43497 | |
| SLPPAPCPSEIQTEP | 631 | Q8N960 | |
| VFLPCEDPPPTPQSS | 176 | Q9BQY9 | |
| GTCPSPPQPLSPAAA | 231 | Q12948 | |
| QPLCPPPSSPTSEGA | 256 | Q9UF56 | |
| FSSPSPSPDSCPSPE | 211 | Q96AQ9 | |
| PSPDSCPSPEEPPST | 216 | Q96AQ9 | |
| CPSPEEPPSTAGIPQ | 221 | Q96AQ9 | |
| RPCSSPSQPPSPDEE | 861 | Q674R7 | |
| SSPELAPPPACPSES | 376 | Q04637 | |
| CEQDRPSPTTAPPAP | 191 | P11279 | |
| PEPPVSQELPCSSEG | 351 | Q66K89 | |
| QPTPLTSEPSACPPG | 266 | Q6ZVF9 | |
| TSEPSACPPGPEKVP | 271 | Q6ZVF9 | |
| CKSTLSPPEASPGPP | 181 | Q6NUJ5 | |
| PPSPIEDSQLDPGCS | 211 | Q8N813 | |
| AQDSPASPCAPPGVP | 56 | O75474 | |
| PSPDGCPELQPTFDP | 351 | Q6ZN04 | |
| TAPPAPEPSACSEPG | 281 | Q2TAK8 | |
| CSPPPEQPTATESLP | 801 | Q8N2Y8 | |
| APDCPETSNQTPPGP | 636 | Q9NXH9 | |
| PDTGPDSELSPCIPP | 201 | Q99932 | |
| PPCQDLPDTSPPSQR | 761 | Q7Z736 | |
| GPHSTLTPPCSPPED | 446 | Q9Y5X2 | |
| SPEPSTCPSGLVPEP | 1066 | Q6ZMQ8 | |
| PGAEPEPEPSTACPQ | 281 | Q8N967 | |
| ENPPPERSPASSPCQ | 226 | Q5VWT5 | |
| RASSDPPEAPCTGPP | 356 | O15197 | |
| LCLPTTPGTPDSSDP | 196 | Q5JR12 | |
| QAPPSLPTQGPSCPA | 791 | Q96T21 | |
| STPPAGPGTSAQPPC | 1056 | Q9P2R6 | |
| TLPPKPAPTGTSCEP | 696 | Q92854 | |
| TEESEPLPSCPGSPP | 96 | O94864 | |
| PNTDPVPTLPAEPCS | 36 | Q9H3Y6 | |
| EPGSTEPNSEPPDPC | 341 | A6NEL2 | |
| PTPPGCSQSELLPGT | 441 | Q96KW2 | |
| SPSEPGSSCSPTPPP | 231 | Q9NZQ3 | |
| GAPLTSPEPSQPPCA | 1001 | Q9H2D6 | |
| PCSPPSPQASSLSGP | 756 | Q8WZ75 | |
| PPETPSPDETSAPCP | 871 | A8K7I4 | |
| GPTGSPPCIQTSPDP | 261 | Q15735 | |
| PGQEPPTPSSCSLPS | 216 | O94827 | |
| DSSQGPCEPLPGPLT | 101 | O15027 | |
| SPDPESPSPQPSCQT | 626 | Q76I76 | |
| PCPAEGTEEPTEPPS | 1441 | Q8IWN7 | |
| ECPPAPTNGTSGPPL | 171 | Q9NWF4 | |
| CTPASPPDSQPPASP | 256 | Q9H6E5 | |
| SPCPEPPSNSTRLPE | 696 | Q96HA7 | |
| PEAPCSPPSVPSAAS | 631 | Q9H9D4 | |
| PPSSPPSASGSCPDD | 176 | P22105 | |
| ISPECPSGPCQTPPQ | 476 | Q96DN2 | |
| PSSDPGLSPTQPCPE | 221 | P28908 | |
| PASPTSPSDCPPALA | 1026 | O94885 | |
| GSCPSSPLPSPAPSV | 496 | Q5SNT2 | |
| VCSSEPAEPPGTPPA | 956 | Q8N398 | |
| PALAETSPTAPECPP | 786 | Q13105 | |
| PQPSSPGPACAEPSS | 96 | Q8N0V1 | |
| QSPCPSRDPAPIPTE | 41 | P52746 | |
| EDQPSEPPSPATTPC | 241 | Q04725 | |
| RCALESPPTSQGPPP | 41 | Q9NSU2 | |
| LPPLPGDDSPTTLCS | 46 | P29353 | |
| SPSGPLEPCPSISAP | 481 | Q9BU19 | |
| PPQESEPCPQSPSAS | 116 | Q49AM3 | |
| PDSPLPPLSTCGESS | 1571 | Q5THJ4 | |
| CSQGDLSVPSPPPDP | 156 | O15069 | |
| LESAPSPCEPSPAPS | 856 | Q8N9H8 | |
| SPCEPSPAPSPASSP | 861 | Q8N9H8 | |
| SNSGEPDIPPPQPDC | 111 | Q9BWU0 | |
| PPCPYLDLEPSPSDS | 1101 | O15399 | |
| PLCPLPSPPTSDSDS | 701 | Q00653 |